bioratherapeutics.com - BIOR Net Assets per Single Share

Graphic logo of Biora Therapeutics (BIOR)

Biora Therapeutics aims to launch innovative gastrointestinal biopharmaceutical delivery systems to partner with industry behemoths. The book value per share reflects capital dynamics, with the indicator currently standing at -29.01. Ambitious bioengineers developing smart capsules are driving this growth, although success remains contingent upon patent protection and clinical trial results.

Biora Therapeutics Inc. (BIOR): Share Book Value from 04/28/2023 to 12/14/2024

bioratherapeutics.com - analytical breakdowns and key metrics (BIOR)

- price and consensus price forecast:
Price Chart Progenity|BIOR - Average Forecast Price
- market capitalization data:
Market Value Biora Therapeutics, Inc.|BIOR - Value Adjusted for Debt and Cash
- book capitalization data:
Net Assets per Single Share Biora Therapeutics|BIOR - Net Asset Value|Market Capitalization to Book Value Ratio bioratherapeutics.com|BIOR - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Biora Therapeutics|BIOR - Long-Term Debt to Capital|Short-Term Debt to Equity Biora Therapeutics, Inc.|BIOR - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Biora Therapeutics, Inc.
Fundamental company valuation:Progenity - BIOR
Manufactured products of Biora Therapeutics, Inc.

Book value per share represents the ratio of a company's net equity to its number of outstanding securities, reflecting the actual value of an investor's stake. An analysis of equity per share allows for tracking the rate of resource depletion at Biora Therapeutics (BIOR) due to the development costs of NaviCap systems amid a lack of revenue and systematic cash burn.

Competitors of Biora Therapeutics (BIOR)

PHAT (Phathom Corp) - Net Assets per Single Share|TERN: Net Asset Value per Share|Net Assets per Single Share ironwoodpharma.com IRWD|CURX (Curanex Pharmaceuticals) - Accounting Value of a Share|Net Assets per Single Share Immuron Ltd IMRN|Share Book Value Evoke Pharma Inc.|Entero Therapeutics, Inc. (ENTO) - Book Value per Share|Accounting Value of a Share redhillbio.com (RDHL)|Book Value per Share PALI (Palisade Bio, Inc.)|jaguar.health - Book Value per Share|Net Assets per Single Share Morphic (MORF)